Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection - Wikidata - wikimedia - TriplyDB

Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection

Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection

http://www.wikidata.org/entity/Q34405543

about

Animal Models for HIV Cure Research Post-transcriptional gene silencing, transcriptional gene silencing and human immunodeficiency virus Considerations in the development of nonhuman primate models of combination antiretroviral therapy for studies of AIDS virus suppression, residual virus, and curative strategies Structural insights on the role of antibodies in HIV-1 vaccine and therapy Multi-dose Romidepsin Reactivates Replication Competent SIV in Post-antiretroviral Rhesus Macaque Controllers Antiretroviral treatment in HIV-infected infants and young children: novel issues raised by the Mississippi baby Quantification of HIV-1 latency reversal in resting CD4+ T cells from patients on suppressive antiretroviral therapy Acute Human Immunodeficiency Virus (HIV) Syndrome After Nonadherence to Antiretroviral Therapy in a Patient With Chronic HIV Infection: A Case Report.A Murine Viral Outgrowth Assay to Detect Residual HIV Type 1 in Patients With Undetectable Viral Loads A curative regimen would decrease HIV prevalence but not HIV incidence unless targeted to an ART-naïve population The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption Brief Report: Relationship Among Viral Load Outcomes in HIV Treatment Interruption Trials.HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice Modelling the evolution of HIV-1 virulence in response to imperfect therapy and prophylaxis Socially-integrated transdisciplinary HIV prevention.HIV eradication: combinatorial approaches to activate latent viruses.UK guideline for the use of HIV Post-Exposure Prophylaxis Following Sexual Exposure, 2015.Intrapatient Evolutionary Dynamics of Human Immunodeficiency Virus Type 1 in Individuals Undergoing Alternative Treatment Strategies with Reverse Transcriptase Inhibitors.Fixed-dose combination emtricitabine/tenofovir/efavirenz initiated during acute HIV infection; 96-week efficacy and durability.Antiretroviral Therapy Interruption Among HIV Postive People Who Use Drugs in a Setting with a Community-Wide HIV Treatment-as-Prevention Initiative.TZA: a novel assay for measuring the latent HIV-1 reservoir.Nonhuman Primate Models for Studies of AIDS Virus Persistence During Suppressive Combination Antiretroviral Therapy.

P2860

Q26767476-F7B267D1-A08E-49D5-929A-7A171C07F9E3 Q26797870-95F0061C-DCD1-424E-9D35-1C9197C22229 Q26825814-FAADAF04-0F18-42F2-8876-3FBB0D9F2388 Q26829461-2A5BF9B2-C26E-4D60-82F2-18B6FC41480F Q27312050-4423EF3B-FBAA-4302-B866-3546F158ECDB Q33557037-DEEC0A44-3D2B-4DF8-B59C-41D30357AC41 Q33627137-69E9BFB5-CEF1-46BE-A628-4FDF8F5242DC Q35072026-66026270-CBAC-4438-86E6-86C864EB79E7 Q36149000-A933E5C2-73B3-4ACE-88A5-F621753A6DDD Q36611180-9A019B80-9F4B-40CB-8C7A-FC3B88824B7D Q36824388-6D40D026-6BF4-49D7-B037-136D47A1654F Q37014116-FDD7BF62-FDF9-4798-A22E-8E8F8D29EFEE Q37236504-BF030A44-1832-4600-841D-98532B78383C Q37661125-BEC758DF-1285-4973-BA6A-CB17D3B6B448 Q37732465-56455BCF-3A9B-4485-9E9E-7E0974BEDC7E Q38271132-1576D199-8B50-4580-BD64-EC72B7609AA6 Q38812601-44CC5C74-6121-4B59-BE7F-7FD36BFD0D6E Q38859119-F184D22D-F585-4606-9D8B-6BC2F8D6B3E4 Q39357415-1D83BD13-2F50-4435-AB02-D62DFE81481E Q40634095-9362F714-64A2-4571-8FE9-5946479A6733 Q41995271-8FF33605-B7FA-4253-9F52-98FD41A94C5C Q45326424-01486A0A-5F51-4235-953B-DDC14545BDE6

P2860

Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection

http://www.wikidata.org/entity/Q34405543

description

2012 nî lūn-bûn

@nan

2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Plasma HIV viral rebound follo ...... mary and chronic HIV infection

@ast

Plasma HIV viral rebound follo ...... mary and chronic HIV infection

@en

Plasma HIV viral rebound follo ...... mary and chronic HIV infection

@nl

type

label

Plasma HIV viral rebound follo ...... mary and chronic HIV infection

@ast

Plasma HIV viral rebound follo ...... mary and chronic HIV infection

@en

Plasma HIV viral rebound follo ...... mary and chronic HIV infection

@nl

prefLabel

Plasma HIV viral rebound follo ...... mary and chronic HIV infection

@ast

Plasma HIV viral rebound follo ...... mary and chronic HIV infection

@en

Plasma HIV viral rebound follo ...... mary and chronic HIV infection

@nl

P1433

Q34405543-8BDE9814-121F-4A98-99B2-32093973B3E8

P1476

Q34405543-13007548-AF3A-4000-9A69-C4B6FF8BD0D3

P2093

Q34405543-45432241-6EF3-4C5B-AA0A-A7004498C34F

Q34405543-464CCB22-4CFC-4469-A2E4-12B5F359B9B7

Q34405543-5EA60D5D-880C-4847-BC19-629091B2691B

Q34405543-7708337F-DB6D-416B-B142-89D9E2D32308

Q34405543-79CBA9BC-395A-4029-AFDD-72D6FB700776

Q34405543-8A6E8015-186E-4831-9847-4614D749AEE7

Q34405543-9E99F7BA-483D-4429-9941-A8E49C9E2E6C

Q34405543-9ED142F4-F9D4-4FA0-828C-BCF253010621

Q34405543-A1D7E0BC-7363-4CB6-8B5F-97315AA8286C

Q34405543-DD24574A-E938-4AB2-96B5-FF04A5E07441

P2860

Q34405543-04828109-FB80-4CF3-B923-CDC5BCBC7013

Q34405543-1E9987D6-607E-4552-8760-95377DA64FBC

Q34405543-22F330E5-FDA4-470B-A4FA-19F09C9CC3A9

Q34405543-293C61A8-9BC6-49B2-81F8-171C86B76E6E

Q34405543-2D077DDE-03D3-4076-BA33-1834144D2751

Q34405543-3147D222-B604-4812-B638-5516F2643B54

Q34405543-39E59A89-94F0-485D-B627-93E51CAFB3B3

Q34405543-408CEA1C-C4A6-4BCE-8995-379D4F38BD1D

Q34405543-42495294-727F-4DD4-BDEA-748EB4D844DA

Q34405543-54573AD9-6413-4C5E-AC9F-5C1B82BA1B11

P304

Q34405543-89A1CFCE-EA92-4580-A033-429AE52BAD03

P31

Q34405543-AF99ECD2-DE69-407F-97CF-0C159FE4C440

P356

Q34405543-35189923-AD99-4CE2-BC9F-A1422BD94E2A

P407

Q34405543-3E6E3CF0-EFE6-4933-B195-9E015DC04E4E

P433

Q34405543-536A2970-1464-4A6F-9630-1EFD1A1B70CE

P478

Q34405543-23C6C2D8-2960-421B-A086-40DF612D7E18

P50

Q34405543-2AE35841-0B34-4F79-9750-57B8B049CA9E

Q34405543-7C0781D5-FB3C-4490-9D79-AC919D654D5A

Q34405543-9EB5EEF9-E676-4305-BC1A-1DD3E85916B6

P577

Q34405543-F21762FD-C2FF-4F70-BBE5-293C06DF1736

P5875

Q34405543-8E945B7D-EA61-44B8-9ECA-0BCC35FC011E

P698

Q34405543-AAD4BA03-708C-48B6-A72E-76888526C702

P932

Q34405543-553778BE-6026-4372-964D-416E26C58517

P356

JOURNAL.PONE.0043754

P1433

P1476

Plasma HIV viral rebound follo ...... mary and chronic HIV infection

@en

P2093

Abdel Babiker

http://www.w3.org/2001/XMLSchema#string

Court Pedersen

http://www.w3.org/2001/XMLSchema#string

David A Cooper

http://www.w3.org/2001/XMLSchema#string

Elizabeth Hamlyn

http://www.w3.org/2001/XMLSchema#string

Fiona M Ewings

http://www.w3.org/2001/XMLSchema#string

INSIGHT SMART and SPARTAC Investigators

http://www.w3.org/2001/XMLSchema#string

Jason F Okulicz

http://www.w3.org/2001/XMLSchema#string

Jonathan Weber

http://www.w3.org/2001/XMLSchema#string

Mauro Schechter

http://www.w3.org/2001/XMLSchema#string

Sarah Fidler

http://www.w3.org/2001/XMLSchema#string

P2860

Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection

Prevention of HIV-1 infection with early antiretroviral therapy

Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

CD4+ count-guided interruption of antiretroviral treatment

Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings.

Should we try to eliminate HIV epidemics by using a 'Test and Treat' strategy?

HIV preferentially infects HIV-specific CD4+ T cells.

Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication.

Episodic antiretroviral therapy increases HIV transmission risk compared with continuous therapy: results of a randomized controlled trial.

P304

e43754

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0043754

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Giuseppe Tambussi

P577

2012-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236990535

http://www.w3.org/2001/XMLSchema#string

P698

22952756

http://www.w3.org/2001/XMLSchema#string

P932

3432055

http://www.w3.org/2001/XMLSchema#string